Inflammation Markers

C-reactive protein is the fast generalist, and the fastest-moving marker on the panel. MedlinePlus describes it as a protein the liver pours into the blood within hours of inflammation starting, one that falls back within days once the trigger clears. The erythrocyte sedimentation rate is the slow counterpart: an indirect measure that averages blood-protein change over days to weeks, so it both rises and settles on a lag. Put plainly, CRP tells you about today and ESR tells you about the recent stretch, and the CRP-versus-ESR comparison is really a comparison of timescales.

Procalcitonin changes the question from how much to what kind. CRP and ESR rise with inflammation from almost any source, so neither can say whether bacteria are behind it. MedlinePlus describes procalcitonin as a marker that tends to climb more with bacterial infection, including sepsis, which is why it is read to help weigh a bacterial cause and inform antibiotic decisions. Serum amyloid A is a quieter member: another acute-phase protein that tracks CRP closely enough that it seldom redraws a picture CRP has already given.

Then there is the marker that doesn't look in the blood at all. Calprotectin is measured in stool, and MedlinePlus describes the fecal calprotectin test as detecting a protein white cells release when the intestinal lining is inflamed. Measuring it in the gut rather than the bloodstream is deliberate: it localizes.

The single most common confusion on this panel is treating CRP and hs-CRP as separate tests. They measure the same liver-made protein. The difference is the scale and the question. Standard CRP is read on a coarse scale to judge whether something is actively inflamed, an infection or a flare, where the values that matter are large. High-sensitivity CRP reads much smaller concentrations because the question is different: long-term cardiovascular risk, where small, steady elevations are the signal. MedlinePlus is explicit that the two are easy to confuse and are used for different conditions, and the CRP-versus-hs-CRP comparison walks through why the same molecule needs two reports.

The practical trap follows directly from that shared chemistry. An hs-CRP drawn in the middle of an illness is not a subtle cardiovascular reading at all, because the infection has driven CRP far past the range hs-CRP was meant to resolve. The number is real, but it answers the wrong question. This is why a low-grade hs-CRP only carries its cardiovascular meaning when it is drawn in a quiet stretch.

For all the markers it carries, an inflammation panel mostly answers whether and how much, not where or why. CRP, ESR, procalcitonin, and serum amyloid A are all blood markers that confirm an inflammatory process and gesture at its intensity or, in procalcitonin's case, lean toward a bacterial cause. None of them names the inflamed organ; when an autoimmune cause is suspected, that question moves to the autoimmune panel. Calprotectin is the exception that proves the rule, and it earns that by being measured somewhere other than the blood.

A normal panel is also less reassuring than it looks. Inflammation that has already resolved leaves CRP low while ESR can still read high, and a localized problem in the gut can sit behind unremarkable blood markers until a stool test goes looking. NIDDK frames conditions like Crohn's disease as inflammation that damages the intestinal wall, which is exactly the kind of localized process a blood panel can underplay. What these markers do well is describe activity and, read together rather than one at a time, hint at its tempo and its kind. The cause is a conversation for your doctor, and the guide to reading inflammation markers covers how a single result fits into a trend.